Tonix Pharmaceuticals has launched Tonmya (cyclobenzaprine), a newly approved oral treatment for adults with fibromyalgia.

TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonmya™ Commercial Launch Underway Following the approval of Tonmya™ ...

People suffering from the chronic pain condition fibromyalgia are being failed by the NHS, according to new research which ...

Here’s what to look for in a fibromyalgia care provider to ensure you get the most compassionate, collaborative treatment.

Discover the National Fibromyalgia Association's mission to enhance life for people with fibromyalgia through awareness, education, support, and advocacy efforts.

Special Report: Entropy Neurodynamics has completed dosing of its IV-infused psilocin TRP-8803 for the first patient ...

In a boost for its phase III Indonesian diabetic foot infection trial, Recce becomes eligible for up to $85 million of ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Expert warns about the viral borax bath trend stating it is unsafe and injurious to skin and health Read ahead to find out ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated commercial-stage biotechnology company today announced the appointment of Irina Ishak as General ...

A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured 7 in 10 type 2 diabetics.

Appoints Irina Ishak As General Counsel. Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated commercial-stage biotechnology company, appointed Irina Ishak as General Counsel effective Dec. 8, ...